Low Dose Treosulfan Based Conditioning Regimen in HSCT for Nijmegen Breakage Syndrome
Status:
Recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
The aim of the current study is to evaluate the safety and efficacy of low dose treosulfan
based conditioning regimen in HSCT in Nijmegen breakage syndrome
Phase:
Phase 2
Details
Lead Sponsor:
Federal Research Institute of Pediatric Hematology, Oncology and Immunology